Consumers survey results of for 1 quarter of 2024 in category Gynecology, urology, nephrology / Medication for the treatment of menstrual cycle and PMS
The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year. |
![](//www.favor.com.ua/i/cache/colordot/C0504D.gif) |
I quarter (january—march) |
![](//www.favor.com.ua/i/cache/colordot/3D9743.gif) |
II quarter (april—june) |
|
1. |
Ременс (Perrigo)
|
50.00%![](//www.favor.com.ua/images/icons/graph.gif) |
5 |
![](//www.favor.com.ua/i/cache/colordot/C0504D.gif) |
2. |
Гінекохеель (Heel)
|
25.00%![](//www.favor.com.ua/images/icons/graph.gif) |
2.50 |
![](//www.favor.com.ua/i/cache/colordot/C0504D.gif) |
2. |
Дисменорм (DHU) |
25.00%![](//www.favor.com.ua/images/icons/graph.gif) |
2.50 |
![](//www.favor.com.ua/i/cache/colordot/C0504D.gif) |
2. |
Мастодинон (Bionorica)
|
25.00%![](//www.favor.com.ua/images/icons/graph.gif) |
2.50 |
![](//www.favor.com.ua/i/cache/colordot/C0504D.gif) |
–. |
Tazalok (Pro-Pharma)
|
0.00%![](//www.favor.com.ua/images/icons/graph.gif) |
0 |
![](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7) |
–. |
Мулімен (Heel)
|
0.00%![](//www.favor.com.ua/images/icons/graph.gif) |
0 |
![](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7) |
–. |
Фемінал (Екомед) |
0.00%![](//www.favor.com.ua/images/icons/graph.gif) |
0 |
![](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7) |
–. |
Циклодінон (Bionorica)
|
0.00%![](//www.favor.com.ua/images/icons/graph.gif) |
0 |
![](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7) | |